(Q38125667)

29 August 2017

title

Anhedonia revisited: is there a role for dopamine-targeting drugs for depression? (English)

1 reference

29 August 2017

0 references

1 reference

2

David J Nutt

0 references

author name string

Spilios V Argyropoulos

series ordinal

1

1 reference

29 August 2017

language of work or name

English

0 references

publication date

31 July 2013

1 reference

Journal of Psychopharmacology

29 August 2017

published in

1 reference

29 August 2017

volume

27

1 reference

29 August 2017

issue

10

1 reference

29 August 2017

page(s)

869-877

1 reference

Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Dopamine neuron systems in the brain: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Functional magnetic resonance imaging of brain reward circuitry in the human

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

The role of dopamine in reward and pleasure behaviour--review of data from preclinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Implications of the DSM's emphasis on sadness and anhedonia in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

A meta-analysis of emotional reactivity in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Scales for physical and social anhedonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Endogenous opioid release in the human brain reward system induced by acute amphetamine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Assessing appetitive and consummatory phases of ethanol self-administration in C57BL/6J mice under operant conditions: regulation by mGlu5 receptor antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Motivation, reward, and Parkinson's disease: influence of dopatherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

The role of dopamine in the pathophysiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Lack of ventral striatal response to positive stimuli in depressed versus normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

No evidence for physical anhedonia as a candidate symptom or an endophenotype in bipolar affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

D2 dopamine receptors and personality traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Assessing anhedonia in psychiatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Aripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

The assessment of anhedonia in clinical and non-clinical populations: further validation of the Snaith-Hamilton Pleasure Scale (SHAPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Which endogenous depressive symptoms relate to REM latency reduction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Reward processing in schizophrenia: a deficit in the representation of value

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Antidepressant drug treatment modifies the neural processing of nonconscious threat cues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Translating scientific opportunity into public health impact: a strategic plan for research on mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Role of the dopaminergic system in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

The neural correlates of anhedonia in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Functional magnetic resonance imaging of reward prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Psychomotor retardation and anhedonia in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Measuring hedonic capacity in depression: a psychometric analysis of three anhedonia scales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Reduced right ventrolateral prefrontal cortex activity while inhibiting positive affect is associated with improvement in hedonic capacity after 8 weeks of antidepressant treatment in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Deficits in sustaining reward responses in subsyndromal and syndromal major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Anhedonia and suicide: a 6.5-yr. follow-up study of patients hospitalised for a suicide attempt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

The dopamine D4 receptor gene 48-base-pair-repeat polymorphism and mood disorders: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Neural representation of reward in recovered depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

The D2 antagonist sulpiride modulates the neural processing of both rewarding and aversive stimuli in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Neural processing of reward and punishment in young people at increased familial risk of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Emotional reactivity in depression: diminished responsiveness to anticipated reward but not to anticipated punishment or to nonreward or avoidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Diagnosing major depressive disorder VIII: are some symptoms better than others?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

The role of the brain reward system in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

The other face of depression, reduced positive affect: the role of catecholamines in causation and cure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Anhedonia, suicide ideation and dexamethasone nonsuppression in depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

"I won, but I'm not getting my hopes up": depression moderates the relationship of outcomes and reward anticipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Catecholamines in the bed nucleus of the stria terminalis reciprocally respond to reward and aversion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Hedonic hot spot in nucleus accumbens shell: where do mu-opioids cause increased hedonic impact of sweetness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Anhedonia in schizophrenia and major depression: state or trait?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Neurobiology of emotion perception I: The neural basis of normal emotion perception

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

A pooled MADRS/IDS cross-correlation analysis: clinician and patient self-report assessment of improvement in core depressive symptoms with adjunctive aripiprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Dopamine transporter binding in depressed patients with anhedonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

A corticosteroid/dopamine hypothesis for psychotic depression and related states

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Does physical anhedonia play a role in depression? A 20-year longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Dopamine enhances expectation of pleasure in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Can recovery from depression be achieved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Ventral pallidum roles in reward and motivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Major depressive disorder is characterized by greater reward network activation to monetary than pleasant image rewards

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Determinants of poor 1-year outcome of DSM-III-R major depression in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Phasic nucleus accumbens dopamine encodes risk-based decision-making behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Assessing the effects of bupropion SR on mood dimensions of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Reconsidering anhedonia in depression: lessons from translational neuroscience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Dopamine: the salient issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Relationship between psychostimulant-induced "high" and dopamine transporter occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

The role of the nucleus accumbens and rostral anterior cingulate cortex in anhedonia: integration of resting EEG, fMRI, and volumetric techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Dopaminergic mechanism of antidepressant action in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Mesolimbic neuronal activity across behavioral states

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

Dynamics of the dopaminergic system as a key component to the understanding of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881113494104

21 January 2018

Identifiers

DOI

10.1177/0269881113494104

1 reference

29 August 2017

1 reference